Related Experiment Video
Updated: Jan 18, 2026

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
The effect of ShotBlocker on pain and satisfaction during measles-rubella-mumps vaccination: A randomized controlled
Veysel Can1, Nesrullah Ayşin2, Mehmet Bulduk1
1Faculty of Health Sciences, Department of Nursing, Van Yüzüncü Yıl University, 65000 Van, Turkey.
Insights
The ShotBlocker device significantly reduced pain and physiological stress during measles-mumps-rubella (MMR) vaccination in infants. This intervention also improved maternal satisfaction with nursing care, offering a low-cost solution for routine immunization.
Area of Science:
- Pediatric Nursing
- Immunization Practices
- Pain Management
Background:
- Infant vaccination, including the measles-mumps-rubella (MMR) vaccine, can cause pain and distress.
- Effective pain management strategies are crucial for positive vaccination experiences and adherence to immunization schedules.
Purpose of the Study:
- To evaluate the impact of the ShotBlocker device on pain perception and maternal satisfaction during infant MMR vaccination.
- To assess physiological stress responses, such as pulse rate, following vaccination with and without the ShotBlocker.
Main Methods:
- A randomized controlled trial involving 60 infants receiving the MMR vaccine.
- Infants were divided into two groups: ShotBlocker intervention (n=30) and routine care (control, n=30).
- Pain was assessed using the FLACC Pain Scale, and satisfaction was measured by the Newcastle Satisfaction with Nursing Care Scale (NEW-SNCS).
Main Results:
- Significantly lower pain scores were observed in the ShotBlocker group during and after vaccination (p < 0.001).
- Mothers reported significantly higher satisfaction with nursing care in the ShotBlocker group (p < 0.001).
- Lower post-vaccination pulse rates in the ShotBlocker group indicated reduced physiological stress (p < 0.001).
Conclusions:
- The ShotBlocker device is effective in reducing vaccination-associated pain and physiological stress in infants.
- It enhances maternal satisfaction with nursing care, suggesting its value in clinical practice.
- The device's low cost and ease of use support its integration into routine immunization protocols.
Aim:
The study aim to evaluate the effect of shotblocker on pain and satisfaction during measles-mumps-rubella vaccination among infants.
Method:
A randomized controlled experimental design was used. The study was conducted between August and October 2024 at a Family Health Centre under the Public Health Directorate in eastern Turkey. The sample consisted of 60 infants receiving MMR vaccination, divided into two groups: the ShotBlocker group (n = 30) and the control group (n = 30). Infants in the ShotBlocker group were vaccinated using the ShotBlocker device, while those in the control group underwent routine vaccination without additional intervention. Data were collected using the FLACC Pain Scale and the Newcastle Satisfaction with Nursing Care Scale (NEW-SNCS). Ethical principles were strictly followed.
Results:
Observations by mothers and nurses indicated significantly lower pain scores during and after vaccination in the ShotBlocker group compared to the control group (p < 0.001). Mothers' satisfaction scores with nursing care were significantly higher in the ShotBlocker group (p < 0.001). Additionally, pulse rates following vaccination were lower in the ShotBlocker group, reflecting reduced physiological stress responses (p < 0.001).
Conclusion:
ShotBlocker effectively reduces vaccination pain, improves maternal satisfaction, and lessens physiological stress. Its low cost and ease of use support its potential for routine immunization. Further studies are needed to assess its effectiveness across different age groups and clinical contexts.
Practice Implications:
ShotBlocker is a simple, low-cost, and effective method to reduce pain and improve parental satisfaction during vaccination, supporting its broader use in practice.
Related Concept Videos
Blinding
Depolarizing Blockers: Pharmocokinetics

